Synthesis of Homogeneous Manganese-Doped Titanium Oxide Nanotubes from Titanate Precursors

We report a novel synthesis route of homogeneously manganese-doped titanium dioxide nanotubes in a broad concentration range. The scroll-type trititanate (H(2)Ti(3)O(7)) nanotubes prepared by hydrothermal synthesis were used as precursors. Mn2+ ions were introduced by an ion exchange method resulting Mn(x)H(2-x)Ti(3)O(7). In a subsequent heat-treatment they were transformed into Mn(y)Ti(1-y)O(2) where y=x/(3+x). The state and the local environment of the Mn2+ ions in the precursor and final products were studied by Electron Spin Resonance (ESR) technique. It was found that the Mn2+ ions occupy two positions: the first having an almost perfect cubic symmetry while the other is in a strongly distorted octahedral site. The ratio of the two Mn2+ sites is independent of the doping level and amounts to 15:85 in Mn(x)H(2-x)Ti(3)O(7) and to 5:95 in Mn(y)Ti(1-y)O(2). SQUID magnetometry does not show long-range magnetic order in the homogeneously Mn2+-doped nanotubes.Comment: 7 pages, 6 figure

Bone Microarchitecture and Strength in Long‐Standing Type 1 Diabetes

Type 1 diabetes (T1DM) is associated with an increased fracture risk, specifically at nonvertebral sites. The influence of glycemic control and microvascular disease on skeletal health in long‐standing T1DM remains largely unknown. We aimed to assess areal (aBMD) and volumetric bone mineral density (vBMD), bone microarchitecture, bone turnover, and estimated bone strength in patients with long‐standing T1DM, defined as disease duration ≥25 years. We recruited 59 patients with T1DM (disease duration 37.7 ± 9.0 years; age 59.9 ± 9.9 years.; body mass index [BMI] 25.5 ± 3.7 kg/m(2); 5‐year median glycated hemoglobin [HbA1c] 7.1% [IQR 6.82–7.40]) and 77 nondiabetic controls. Dual‐energy X‐ray absorptiometry (DXA), high‐resolution peripheral quantitative computed tomography (HRpQCT) at the ultradistal radius and tibia, and biochemical markers of bone turnover were assessed. Group comparisons were performed after adjustment for age, gender, and BMI. Patients with T1DM had lower aBMD at the hip (p < 0.001), distal radius (p = 0.01), lumbar spine (p = 0.04), and femoral neck (p = 0.05) as compared to controls. Cross‐linked C‐telopeptide (CTX), a marker of bone resorption, was significantly lower in T1DM (p = 0.005). At the distal radius there were no significant differences in vBMD and bone microarchitecture between both groups. In contrast, patients with T1DM had lower cortical thickness (estimate [95% confidence interval]: −0.14 [−0.24, −0.05], p < 0.01) and lower cortical vBMD (−28.66 [−54.38, −2.93], p = 0.03) at the ultradistal tibia. Bone strength and bone stiffness at the tibia, determined by homogenized finite element modeling, were significantly reduced in T1DM compared to controls. Both the altered cortical microarchitecture and decreased bone strength and stiffness were dependent on the presence of diabetic peripheral neuropathy. In addition to a reduced aBMD and decreased bone resorption, long‐standing, well‐controlled T1DM is associated with a cortical bone deficit at the ultradistal tibia with reduced bone strength and stiffness. Diabetic neuropathy was found to be a determinant of cortical bone structure and bone strength at the tibia, potentially contributing to the increased nonvertebral fracture risk. © 2022 The Authors. Journal of Bone and Mineral Research published by Wiley Periodicals LLC on behalf of American Society for Bone and Mineral Research (ASBMR)

{2,2′-[o-Phenyl­enebis(nitrilo­methyl­idyne)]diphenolato}dipyridinecobalt(III) perchlorate

The title compound, [Co(C20H14N2O2)(C5H5N)2]ClO4 or [Co(salophen)(py)2]ClO4, where salophen is o-phenyl­enebis(nitrilo­methyl­idyne)]diphenolate and py is pyridine, contains a six-coordinate mononuclear cobalt(III) atom. The two phenolic O atoms and the two imine N atoms are located in cis positions. There are two pyridine mol­ecules attached to the metal atom, filling the axial sites with a mutually perpendicular disposition of the pyridine planes [86.11 (5)°]. The Co complexes are stacked in layers parallel to (100). Coherence of the structure is provided by a variety of C—H⋯O interactions between the complexes and the perchlor­ate counter anion

Precision of bone mechanoregulation assessment in humans using longitudinal high-resolution peripheral quantitative computed tomography in vivo.

Local mechanical stimuli in the bone microenvironment are essential for the homeostasis and adaptation of the skeleton, with evidence suggesting that disruption of the mechanically-driven bone remodelling process may lead to bone loss. Longitudinal clinical studies have shown the combined use of high-resolution peripheral quantitative computed tomography (HR-pQCT) and micro-finite element analysis can be used to measure load-driven bone remodelling in vivo; however, quantitative markers of bone mechanoregulation and the precision of these analyses methods have not been validated in human subjects. Therefore, this study utilised participants from two cohorts. A same-day cohort (n = 33) was used to develop a filtering strategy to minimise false detections of bone remodelling sites caused by noise and motion artefacts present in HR-pQCT scans. A longitudinal cohort (n = 19) was used to develop bone imaging markers of trabecular bone mechanoregulation and characterise the precision for detecting longitudinal changes in subjects. Specifically, we described local load-driven formation and resorption sites independently using patient-specific odds ratios (OR) and 99 % confidence intervals. Conditional probability curves were computed to link the mechanical environment to the remodelling events detected on the bone surface. To quantify overall mechanoregulation, we calculated a correct classification rate measuring the fraction of remodelling events correctly identified by the mechanical signal. Precision was calculated as root-mean-squared averages of the coefficient of variation (RMS-SD) of repeated measurements using scan-rescan pairs at baseline combined with a one-year follow-up scan. We found no significant mean difference (p < 0.01) between scan-rescan conditional probabilities. RMS-SD was 10.5 % for resorption odds, 6.3 % for formation odds, and 1.3 % for correct classification rates. Bone was most likely to be formed in high-strain and resorbed in low-strain regions for all participants, indicating a consistent, regulated response to mechanical stimuli. For each percent increase in strain, the likelihood of bone resorption decreased by 2.0 ± 0.2 %, and the likelihood of bone formation increased by 1.9 ± 0.2 %, totalling 38.3 ± 1.1 % of strain-driven remodelling events across the entire trabecular compartment. This work provides novel robust bone mechanoregulation markers and their precision for designing future clinical studies